| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,234 |
3,293 |
$285K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,641 |
3,960 |
$223K |
| 36415 |
Collection of venous blood by venipuncture |
4,486 |
3,842 |
$92K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,400 |
1,214 |
$67K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
331 |
294 |
$37K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
505 |
463 |
$34K |
| 80053 |
Comprehensive metabolic panel |
473 |
430 |
$34K |
| 99215 |
Prolong outpt/office vis |
305 |
259 |
$34K |
| A0425 |
Ground mileage, per statute mile |
59 |
51 |
$13K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
267 |
257 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
170 |
151 |
$8K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
17 |
13 |
$7K |
| 90677 |
|
12 |
12 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
55 |
50 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
53 |
48 |
$5K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
148 |
129 |
$4K |
| 80050 |
General health panel |
15 |
13 |
$4K |
| 91322 |
|
45 |
44 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
82 |
79 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
34 |
32 |
$3K |
| 0002A |
|
62 |
59 |
$2K |
| 92552 |
|
118 |
115 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
39 |
37 |
$2K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
41 |
39 |
$2K |
| 0001A |
|
82 |
70 |
$2K |
| 87428 |
|
92 |
58 |
$2K |
| 90480 |
|
45 |
44 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
45 |
28 |
$1K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
17 |
17 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
37 |
36 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
96 |
94 |
$873.15 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
17 |
17 |
$835.28 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12 |
12 |
$733.34 |
| 90682 |
|
21 |
21 |
$722.80 |
| 90686 |
|
73 |
73 |
$430.08 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
80 |
78 |
$356.99 |
| 91300 |
|
36 |
25 |
$334.06 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
90 |
64 |
$333.66 |
| 99173 |
|
129 |
126 |
$171.81 |
| G0008 |
Administration of influenza virus vaccine |
15 |
15 |
$97.92 |
| X5622 |
|
59 |
59 |
$0.00 |